GROWBLOX SCIENCES (GBLX) on Focus After Interesting Change

December 15, 2017 – By Max Morgan

GROWBLOX SCIENCES (GBLX) on Focus After Interesting Change

Interested investors have been looking for information on shares of GROWBLOX SCIENCES (OTCMKTS:GBLX) after the stock moved $-0.009, hitting the $0.325 price point in a recent trade.

It’s the latest price, but let’s analyze how the stock has been doing recently. In the past year, GROWBLOX SCIENCES’s stock was big mover. According to the short interest report published recently, (GBLX) had 93,200 shorted shares for 0.1 days to cover. The prior short interest was 22,600 for a $312.39 change. The 52-Week High and Low are noted here. -56.08 % (High), 54.76 %, (Low). The stock had 1.24 million average volume.

Enroll for Our Newsletter Today and know if shares price of GROWBLOX SCIENCES (OTCMKTS:GBLX) is Ready to Breakout!

Penny stocks are often stated as risky investments that hardly pay off. Admittedly, there is fact to this, but with the right knowledge and tactics, it is possible to earn a significant amount of gain in penny stocks. Simply said, a penny stock is an equity that trades at a low price.

Irrespective of the name, penny stocks usually are priced over a penny, occupying a price range at or close to $1, though some are priced a fraction of a penny. Often referred to as micro-cap equities, the Securities & Exchange Commission classifies these types of securities as being $5 or less. Over-the-counter stocks are NOT listed on any of the formal exchanges.

So, penny stocks frequently fit in this segment, though many dodge this category. Over-the-counter (OTC) equities are stated to be risky as they aren’t contingent to the listing and reporting requirements of the reputed commodity exchanges.

Register in the Bar Below to Obtain Breaking Alerts on Shares That Are Set to Make a Move!

Penny shares can be listed on NASDAQ or other known stock exchanges, although many more cannot be found there. A major percentage of penny stocks are listed on the so-named ‘pink sheets’, i.e., daily news of OTC shares. They can even be seen on the ‘Over-the-Counter Bulletin Board.’ Commodities listed on the OTCBB fail to fulfill the listing guidelines of the NYSE or other known exchanges, although they are mandated to file financial statements with known regulators, such as the SEC. Penny shares are inexpensive, thus attractive to shareholders who lack the funds to buy comparatively expensive blue-chip stocks from large firms.

Penny stocks boast immense profit potential. Because these stocks trade cheap, even a slight jump in price turns to be profitable. Look out, however, because frequently shareholders may have trouble getting a decent amount of details about penny stocks. These kinds of shares tend to be latest in news, with almost no track record for investors research.

In addition, penny stocks show lack of market activity, with poor liquidity, making them difficult to sell. Poor liquidity results in penny stocks to be open to price influence.

A shady trader can simply buy large sums of shares, temporarily leading up the price, crafting artificial demand.

Disclaimer: Nothing mentioned in this publication is planned to constitute legal, securities, tax, or investment advice, nor a viewpoint regarding the relevance of any investment, nor any type of solicitation. The general information mentioned in this article should not be acted upon without getting specific tax, legal and investment advice from a certified professional.

More notable recent GB Sciences, Inc. (OTCMKTS:GBLX) news were published by: which released: “GB Sciences: Develops Extremely High THC Content Cannabis Strain With …” on December 13, 2017, also with their article: “GB Sciences is Happy” published on November 13, 2017, published: “GB Sciences Announces Opening of Las Vegas, Nevada, Indoor Cannabis Grow …” on January 04, 2017. More interesting news about GB Sciences, Inc. (OTCMKTS:GBLX) were released by: and their article: “GB Sciences partners with Kush Cups” published on April 10, 2017 as well as‘s news article titled: “GB Sciences Inc. Adds Provisional Nevada Recreational Cannabis License for …” with publication date: July 10, 2017.

GB Sciences, Inc., through its subsidiaries, focuses on the development of cannabis plant into medicines, therapies, and treatments for various ailments. The company has market cap of $76.98 million. The firm intends to produce medical-grade cannabis, cannabis concentrates, and cannabinoid therapies through various technologies in plant biology, cultivation, and extraction techniques combined with biotechnology. It currently has negative earnings. It also focuses on the manufacture, production, leasing, and licensing of GrowBLOX, a controlled-climate indoor agricultural technology growing and cultivation chamber to produce medical grade cannabis and other plant extracts, as well as providing remote diagnostic monitoring and servicing of growing chambers to third party growers and processors of hemp, cannabis, and other plant extracts.

Receive News & Ratings Via Email – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings with our FREE daily email newsletter.

Source link

Leave a Reply